Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials-Reference-Cited by-同舟云学术

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials

Published:2022-04 Issue:2 Volume:7 Page:100425
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Nassif E.F.,Blay J.-Y.,Massard C.,Dufresne A.,Brahmi M.,Cassier P.,Ray-Coquard I.,Pautier P.,Leary A.,Sunyach M.-P.,Bahleda R.,Levy A.,Le Pechoux C.,Honoré C.,Mir O.,Le Cesne A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule;Benjamin;Cancer,1974

2. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial;Judson;Lancet Oncol,2014

3. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial;Tap;Lancet Oncol,2017

4. Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group

5. Making the best of available options for optimal sarcoma treatment;Le Cesne;Oncology,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis;Cancers;2024-05-11

2. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101);Clinical Cancer Research;2023-04-14

3. Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database;Frontiers in Oncology;2023-01-18